CCN2 and neoplasm: Future studies would address this hypothesis by examining the effect of CTGF inhibition on cisplatin-resistant tumor growth and survival; we are currently preparing for studies to investigate FG-3019 efficacy in cisplatin-resistant HGSOC patient-derived xenografts.